Europe Next Generation Sequencing Market Set to Reach US$ 7,685.4 Mn in 2025 - ResearchAndMarkets.com

The "Europe Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product; Service; Application; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

The genomics market is comprised of various technologies such next generation sequencing (NGS), genome editing, gene synthesis and more. These technologies have been utilized for achieving various discoveries for the betterment of the health conditions across living organisms. Next generation sequencing is widely used in the medical field to understand the genetic composition of patients. The use of NGS has been utilized for the alteration of plants and animals for desired physical and genetic changes. The technology is used to produce biomarkers. Biomarkers are widely used in clinical research and clinical practice. NGS is among the important developments in genomic technologies, the technology is used for the discovery of oncogenic biomarker and diagnostics. Developments in whole genome sequencing has enabled the identification of genes required in the large number of diseases, and biomarkers that indicate disease severity to treatment are gradually being characterized. Therefore, the use of the NGS for the discovery of biomarkers has benefited the early diagnosis and differentiating in disease types.

In 2017, the consumables segment held the largest market share of 64.0% of the next generation sequencing market, by product. The segment is growing due to the consumables offered by various companies being widely accepted by consumers and it provides accuracy and precision in the preparation of the NGS. Furthermore, this segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

The diagnostics segment is anticipated to grow at a CAGR of 22.0% during the forecast period owing to the growth of technological advancements such as sequencing machines in the developed and developing regions. Moreover, the similar segment held the largest market share of 34.0% for the application segment in the next generation sequencing market and is likely to dominate the market in coming forecast period.

Some of the major primary and secondary sources for next generation sequencing included in the report are, Non-Invasive Prenatal Testing (NIPT), Food and Drug Administration (FDA), Developing an European - American NGS Network (DEANN), Foreign Direct Investment (FDI) and among others.

Key Topics Covered:

Part 1. Introduction

Part 2. Europe Next Generation Sequencing Market - Key Takeaways

Part 3. Europe Next Generation Sequencing Market - Market Landscape

Part 4. Europe Next Generation Sequencing Market - Key Market Dynamics

Part 5. Next Generation Sequencing Market - Europe Analysis

Part 6. Europe Next Generation Sequencing Market Analysis - By Product

Part 7. Europe Next Generation Sequencing Market Analysis - By Technology

Part 8. Europe Next Generation Sequencing Market Analysis - By Application

Part 9. Europe Next Generation Sequencing Market Analysis - By End USer

Part 10. Europe Next Generation Sequencing Market Revenue And Forecasts To 2025

Part 11. Next Generation Sequencing Market -Industry Landscape

Part 12. Next Generation Sequencing Market - Key Company Profiles

Part 13. Appendix

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.

For more information about this report visit https://www.researchandmarkets.com/r/z2exgn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts:

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.